about
Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumorsRelevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials.Implications of lymph node retrieval in locoregional rectal cancer treated with chemoradiotherapy: a California Cancer Registry Study.Geographic variation of racial/ethnic disparities in colorectal cancer testing among medicare enrollees.Phase II clinical trials on investigational drugs for the treatment of pancreatic cancersFibroblast growth factor signaling in non-small-cell lung cancer.Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy
P50
Q34129269-0239C3A9-366C-47EB-9938-E81DB0ECAE37Q34452827-083137B3-9BB5-416F-B3B4-014C0765D688Q35527095-F7F8968D-CC60-48CA-A30D-CB3678082753Q36062645-315552F3-1DCD-423C-9221-971F709923F9Q36384541-B6097F49-018C-41CD-BE9E-BB63A358FCB7Q37940753-3E497AD7-1CE6-4612-A2DA-9EE940D68FC0Q89582054-809BD680-B00D-4272-952C-49C5BA752336
P50
description
researcher ORCID ID = 0000-0002-7810-5887
@en
wetenschapper
@nl
name
Thomas J Semrad
@ast
Thomas J Semrad
@en
Thomas J Semrad
@es
Thomas J Semrad
@nl
type
label
Thomas J Semrad
@ast
Thomas J Semrad
@en
Thomas J Semrad
@es
Thomas J Semrad
@nl
prefLabel
Thomas J Semrad
@ast
Thomas J Semrad
@en
Thomas J Semrad
@es
Thomas J Semrad
@nl
P1153
7801657447
P31
P496
0000-0002-7810-5887